ICLR ICON Public Limited Company
ICLR ICON Public Limited Company
Healthcare · Diagnostics & Research
Desk view
Market read
POC $166.71 · VWAP $138.93 · +33.4% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, CFO + 7 others sold $1.7M, Aug 11–12
Coverage
2 watchlists
ICLR Price Structure
Loading timeframes…
Peers
Every watchlist ICLR belongs to, members best 30-day change first — ICLR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
@ibb
Reported the quarter ending 2026-06-30: revenue $2.06B, diluted EPS $0.94, net income $73M (SEC filing). Across the print the stock moved -8.2% (close before → first close after).
full note →Against street estimates
How ICLR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about ICLR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 23
- ICON Public Limited Company: Fonds d'Investissement et OPCVM en Position | ICLR | IE0005711209 | Zonebourse
- ICON Public Limited Company (ICLR) Stock Price, News, Quote & History - Yahoo Finance
- ICLR Stock Price | Icon PLC Stock Quote (U.S.: Nasdaq) | MarketWatch
- Form 6-K for Icon PLC filed 10/08/2026
- ICON Reports Second Quarter 2026 Results | ICON plc
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ICLR research tape
3 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.